US SB207 | 2017-2018 | 115th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on January 24 2017 - 25% progression, died in chamber
Action: 2018-06-19 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 24 2017 - 25% progression, died in chamber
Action: 2018-06-19 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
Text: Latest bill text (Introduced) [PDF]
Summary
SALTS Act Synthetic Abuse and Labeling of Toxic Substances Act of 2017 (Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)
Title
SALTS Act Synthetic Abuse and Labeling of Toxic Substances Act of 2017
Sponsors
| Sen. Amy Klobuchar [D-MN] | Sen. Lindsey Graham [R-SC] | Sen. Dianne Feinstein [D-CA] | Sen. Chuck Grassley [R-IA] |
| Sen. Sheldon Whitehouse [D-RI] | Sen. John Cornyn [R-TX] | Sen. Richard Blumenthal [D-CT] | Sen. Thom Tillis [R-NC] |
| Sen. Mark Warner [D-VA] | Sen. Orrin Hatch [R-UT] | Sen. Margaret Hassan [D-NH] | Sen. Marco Rubio [R-FL] |
| Sen. Edward Markey [D-MA] | Sen. John Kennedy [R-LA] | Sen. Tina Smith [D-MN] | Sen. Christopher Coons [D-DE] |
| Sen. John Hoeven [R-ND] | Sen. Jeanne Shaheen [D-NH] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-06-19 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 472. |
| 2018-06-19 | Senate | Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report. |
| 2018-05-24 | Senate | Committee on the Judiciary. Ordered to be reported without amendment favorably. |
| 2018-04-11 | Senate | Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held. |
| 2017-01-24 | Senate | Read twice and referred to the Committee on the Judiciary. |
Same As/Similar To
HB6047 (Related) 2018-07-30 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HB2851 (Related) 2018-06-18 - Received in the Senate and Read twice and referred to the Committee on the Judiciary.
HB2851 (Related) 2018-06-18 - Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Subjects
Crime and law enforcement
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Evidence and witnesses
Marketing and advertising
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Evidence and witnesses
Marketing and advertising
